State of Alaska Department of Revenue’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$612K Sell
16,929
-5,094
-23% -$174K 0.01% 1319
2026
Q1
$727K Sell
22,023
-352
-2% -$14.9K 0.01% 1245
2025
Q4
$1.03M Buy
22,375
+6,523
+41% +$273K 0.01% 1051
2025
Q3
$554K Sell
15,852
-3,275
-17% -$114K 0.01% 1370
2025
Q2
$564K Buy
19,127
+1,257
+7% +$35.9K 0.01% 1312
2025
Q1
$533K Sell
17,870
-404
-2% -$12.3K 0.01% 1341
2024
Q4
$523K Sell
18,274
-110
-0.6% -$3.64K 0.01% 1368
2024
Q3
$710K Sell
18,384
-824
-4% -$29.4K 0.01% 1241
2024
Q2
$618K Sell
19,208
-659
-3% -$22.9K 0.01% 1275
2024
Q1
$771K Sell
19,867
-196
-1% -$6.86K 0.01% 1183
2023
Q4
$617K Sell
20,063
-1,563
-7% -$39.2K 0.01% 1252
2023
Q3
$483K Sell
21,626
-1,137
-5% -$25.9K 0.01% 1335
2023
Q2
$489K Sell
22,763
-226
-1% -$5.13K 0.01% 1377
2023
Q1
$551K Sell
22,989
-389
-2% -$10.3K 0.01% 1318
2022
Q4
$542K Sell
23,378
-249
-1% -$5.02K 0.01% 1317
2022
Q3
$378K Sell
23,627
-2,071
-8% -$36.5K 0.01% 1440
2022
Q2
$455K Buy
25,698
+1,650
+7% +$27.8K 0.01% 1396
2022
Q1
$489K Sell
24,048
-430
-2% -$8.12K 0.01% 1399
2021
Q4
$457K Sell
24,478
-1,450
-6% -$28.3K ﹤0.01% 1488
2021
Q3
$511K Buy
25,928
+1,540
+6% +$33.3K 0.01% 1449
2021
Q2
$576K Buy
24,388
+858
+4% +$19.8K 0.01% 1387
2021
Q1
$557K Buy
+23,530
New +$559K 0.01% 1380

Other funds holding COLL

State of Alaska Department of Revenue's COLL Position: Q2 2026 in Review

State of Alaska Department of Revenue reduced its Collegium Pharmaceutical (COLL) stake by 23% in Q2 2026, selling an estimated $174K and leaving 16,929 shares worth $612K. The position accounts for 0.01% of the portfolio, ranked #1319.

State of Alaska Department of Revenue first reported a position in COLL in Q1 2021 and has held it in 22 quarters since. The position peaked at $1.03M in Q4 2025. 170 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • State of Alaska Department of Revenue held 16,929 shares of Collegium Pharmaceutical worth $612K as of Q2 2026.
  • State of Alaska Department of Revenue sold 5,094 Collegium Pharmaceutical shares in Q2 2026, an estimated $174K.
  • Collegium Pharmaceutical made up 0.01% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #1319 holding.
  • State of Alaska Department of Revenue first reported a position in Collegium Pharmaceutical in Q1 2021 and has held it in 22 quarters since.
  • State of Alaska Department of Revenue's Collegium Pharmaceutical position peaked at $1.03M in Q4 2025.
  • 170 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.